NCT01716949 Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT01711242 Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma Status COMPLETED Phase PHASE2
NCT01710592 A Phase II Trial of Epirubicin, Oxaliplatin and Capecitabine (EOX) Versus Docetaxel and Oxaliplatin (ElTax) in the Treatment of Advanced Gastro-oesophageal Cancer Status COMPLETED Phase PHASE2
NCT01705106 Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies Status TERMINATED Phase PHASE1
NCT01705002 Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors. Status COMPLETED Phase PHASE1
NCT01702558 A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) Status TERMINATED Phase PHASE2
NCT01697072 First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma Status TERMINATED Phase PHASE3
NCT01696695 An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT01677884 Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy Status COMPLETED Phase PHASE2
NCT01665274 Efficiency of XELOX Neoadjuvant Chemotherapy in Gastric Cancer Status TERMINATED Phase PHASE2
NCT01664494 An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer Status COMPLETED Phase N/A
NCT01655992 A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC) Status TERMINATED Phase PHASE3
NCT01640665 Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors Status COMPLETED Phase PHASE1
NCT01634685 A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma Status COMPLETED Phase PHASE1
NCT01630083 Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer Status COMPLETED Phase PHASE2
NCT01611506 Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01609127 Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT01589419 A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE1